Literature DB >> 29963858

Self-Assembled Double-Bundle DNA Tetrahedron for Efficient Antisense Delivery.

Juanjuan Yang1, Qiao Jiang2, Lin He1, Pengfei Zhan2, Qing Liu2, Shaoli Liu2, Meifang Fu2, Jianbing Liu2, Can Li1, Baoquan Ding2,3.   

Abstract

DNA nanostructures are promising biomaterials capable of arranging multiple functional components with nanometer precision. Here, a double-bundle DNA tetrahedron is rationally designed to integrate with antisense oligonucleotides silencing proto-oncogene c-raf and nuclear targeting peptides. The functionalized DNA tetrahedron can be internalized by A549 cells and assists the delivery of antisense oligonucleotides toward the nucleus to increase the chance to downregulate target mRNA in nucleus and cytoplasm. Antisense strands released from the tetrahedron in response to the intracellular reducing environment can inhibit cell proliferation at a low concentration without transfection reagent. Finally, efficient knockdown of c-raf gene is observed, which verified our design. This designer DNA-based nanocarrier system will open a new avenue for efficient delivery of nucleic acid drugs.

Entities:  

Keywords:  antisense oligonucleotides; cancer therapy; double-bundle DNA tetrahedron; drug delivery; self-assembly

Mesh:

Substances:

Year:  2018        PMID: 29963858     DOI: 10.1021/acsami.8b07889

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  13 in total

1.  Lysosomal escaped protein nanocarriers for nuclear-targeted siRNA delivery.

Authors:  Xiuping Cao; Xinxin Shang; Yingshu Guo; Xiaofei Zheng; Wenxin Li; Di Wu; Li Sun; Shanliang Mu; Chuanen Guo
Journal:  Anal Bioanal Chem       Date:  2021-03-26       Impact factor: 4.142

2.  Construction of nanocarriers based on nucleic acids and their applications in nanobiology delivery systems.

Authors:  Yingshu Guo; Xiuping Cao; Xiaofei Zheng; S K Jahir Abbas; Juan Li; Weihong Tan
Journal:  Natl Sci Rev       Date:  2022-01-17       Impact factor: 23.178

3.  Disulfide Bridging Strategies in Viral and Nonviral Platforms for Nucleic Acid Delivery.

Authors:  Kingshuk Dutta; Ritam Das; Jewel Medeiros; S Thayumanavan
Journal:  Biochemistry       Date:  2021-01-11       Impact factor: 3.162

Review 4.  Tetrahedral DNA nanostructures as drug delivery and bioimaging platforms in cancer therapy.

Authors:  Ratchanee Duangrat; Anuttara Udomprasert; Thaned Kangsamaksin
Journal:  Cancer Sci       Date:  2020-07-20       Impact factor: 6.716

Review 5.  Pharmaceutical applications of framework nucleic acids.

Authors:  Liang Chen; Jie Zhang; Zhun Lin; Ziyan Zhang; Miao Mao; Jiacheng Wu; Qian Li; Yuanqing Zhang; Chunhai Fan
Journal:  Acta Pharm Sin B       Date:  2021-05-26       Impact factor: 11.413

6.  A DNA-based nanocarrier for efficient cancer therapy.

Authors:  Muhammad Abbas; Mirza Muhammad Faran Ashraf Baig; Yaliang Zhang; Yu-Shun Yang; Songyu Wu; Yiqiao Hu; Zhong-Chang Wang; Hai-Liang Zhu
Journal:  J Pharm Anal       Date:  2020-03-09

7.  Loop-armed DNA tetrahedron nanoparticles for delivering antisense oligos into bacteria.

Authors:  Yue Hu; Zhou Chen; Xinggang Mao; Mingkai Li; Zheng Hou; Jingru Meng; Xiaoxing Luo; Xiaoyan Xue
Journal:  J Nanobiotechnology       Date:  2020-08-04       Impact factor: 10.435

8.  Self-Assembled DNA Nanostructure as a Carrier for Targeted siRNA Delivery in Glioma Cells.

Authors:  Yanghao Zhou; Qiang Yang; Feng Wang; Zunjie Zhou; Jing Xu; Si Cheng; Yuan Cheng
Journal:  Int J Nanomedicine       Date:  2021-03-03

Review 9.  Tetrahedral DNA nanostructures for effective treatment of cancer: advances and prospects.

Authors:  Jianqin Yan; Xiaohui Zhan; Zhuangzhuang Zhang; Keqi Chen; Maolong Wang; Yong Sun; Bin He; Yan Liang
Journal:  J Nanobiotechnology       Date:  2021-12-07       Impact factor: 10.435

10.  DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases.

Authors:  Nan Zhang; Brittani Bewick; Jason Schultz; Anjana Tiwari; Robert Krencik; Aijun Zhang; Kaho Adachi; Guangbin Xia; Kyuson Yun; Partha Sarkar; Tetsuo Ashizawa
Journal:  Neurotherapeutics       Date:  2021-06-23       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.